# Coherent Corp.: financial statements, quarterly

COHR · NYSE · CIK 820318 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cohr.md) · [Financials](/companies/cohr/financials.md) · [Filings](/companies/cohr/filings.md) · [Insiders](/companies/cohr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cohr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,053](/filings/0000820318-24-000035.md) | [1,131](/filings/0000820318-25-000004.md) | [1,209](/filings/0000820318-25-000009.md) | [1,314 d](/filings/0000820318-26-000020.md) | [1,348](/filings/0000820318-25-000019.md) | [1,435](/filings/0000820318-26-000006.md) | [1,498](/filings/0000820318-26-000013.md) | [1,529 d](/filings/0000820318-26-000020.md) | [1,581](/filings/0000820318-25-000019.md) | [1,686](/filings/0000820318-26-000006.md) | [1,806](/filings/0000820318-26-000013.md) | [2,046 d](/filings/0000820318-26-000020.md) |
| Cost of revenue | $m | [746](/filings/0000820318-24-000035.md) | [781](/filings/0000820318-25-000004.md) | [842](/filings/0000820318-25-000009.md) | [882 d](/filings/0000820318-26-000020.md) | [888](/filings/0000820318-25-000019.md) | [925](/filings/0000820318-26-000006.md) | [970](/filings/0000820318-26-000013.md) | [983 d](/filings/0000820318-26-000020.md) | [1,002](/filings/0000820318-25-000019.md) | [1,063](/filings/0000820318-26-000006.md) | [1,126](/filings/0000820318-26-000013.md) | [1,258 d](/filings/0000820318-26-000020.md) |
| Research and development | $m | [113](/filings/0000820318-24-000035.md) | [111](/filings/0000820318-25-000004.md) | [127](/filings/0000820318-25-000009.md) | [127 d](/filings/0000820318-26-000020.md) | [132](/filings/0000820318-25-000019.md) | [144](/filings/0000820318-26-000006.md) | [151](/filings/0000820318-26-000013.md) | [156 d](/filings/0000820318-26-000020.md) | [155](/filings/0000820318-25-000019.md) | [166](/filings/0000820318-26-000006.md) | [186](/filings/0000820318-26-000013.md) | [216 d](/filings/0000820318-26-000020.md) |
| Selling, general and administrative | $m | [212](/filings/0000820318-24-000035.md) | [209](/filings/0000820318-25-000004.md) | [205](/filings/0000820318-25-000009.md) | [228 d](/filings/0000820318-26-000020.md) | [229](/filings/0000820318-25-000019.md) | [221](/filings/0000820318-26-000006.md) | [231](/filings/0000820318-26-000013.md) | [245 d](/filings/0000820318-26-000020.md) | [252](/filings/0000820318-25-000019.md) | [258](/filings/0000820318-26-000006.md) | [268](/filings/0000820318-26-000013.md) | [266 d](/filings/0000820318-26-000020.md) |
| Operating income | $m | [(21.3)](/filings/0000820318-23-000029.md) | [31.9](/filings/0000820318-24-000004.md) | [22.3](/filings/0000820318-24-000009.md) | [63.2 d](/filings/0000820318-24-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [73.3](/filings/0000820318-23-000029.md) | [74.7](/filings/0000820318-24-000004.md) | [72.8](/filings/0000820318-24-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(20.8)](/filings/0000820318-24-000035.md) | [(8.9)](/filings/0000820318-25-000004.md) | [(16.1)](/filings/0000820318-25-000009.md) | [56.9 d](/filings/0000820318-26-000020.md) | [(5.6)](/filings/0000820318-25-000019.md) | [26.9](/filings/0000820318-26-000006.md) | [8.1](/filings/0000820318-26-000013.md) | [34.7 d](/filings/0000820318-26-000020.md) | [(8.3)](/filings/0000820318-25-000019.md) | [24.2](/filings/0000820318-26-000006.md) | [2.7](/filings/0000820318-26-000013.md) | [42.3 d](/filings/0000820318-26-000020.md) |
| Net income | $m | [(67.5)](/filings/0000820318-24-000035.md) | [(27.0)](/filings/0000820318-25-000004.md) | [(13.2)](/filings/0000820318-25-000009.md) | [(48.4) d](/filings/0000820318-26-000020.md) | [25.9](/filings/0000820318-25-000019.md) | [103](/filings/0000820318-26-000006.md) | [15.7](/filings/0000820318-26-000013.md) | [(95.6) d](/filings/0000820318-26-000020.md) | [226](/filings/0000820318-25-000019.md) | [147](/filings/0000820318-26-000006.md) | [191](/filings/0000820318-26-000013.md) | [241 d](/filings/0000820318-26-000020.md) |
| Diluted EPS | $ per share | [(0.65)](/filings/0000820318-24-000035.md) | [(0.38)](/filings/0000820318-25-000004.md) | [(0.29)](/filings/0000820318-25-000009.md) | not reported | [(0.04)](/filings/0000820318-25-000019.md) | [0.44](/filings/0000820318-26-000006.md) | [(0.11)](/filings/0000820318-26-000013.md) | not reported | [1.19](/filings/0000820318-25-000019.md) | [0.76](/filings/0000820318-26-000006.md) | [0.97](/filings/0000820318-26-000013.md) | not reported |
| Basic EPS | $ per share | [(0.65)](/filings/0000820318-24-000035.md) | [(0.38)](/filings/0000820318-25-000004.md) | [(0.29)](/filings/0000820318-25-000009.md) | not reported | [(0.04)](/filings/0000820318-25-000019.md) | [0.46](/filings/0000820318-26-000006.md) | [(0.11)](/filings/0000820318-26-000013.md) | not reported | [1.24](/filings/0000820318-25-000019.md) | [0.87](/filings/0000820318-26-000006.md) | [1.01](/filings/0000820318-26-000013.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0000820318-24-000035.md) | [0.9](/filings/0000820318-25-000004.md) | [0.9](/filings/0000820318-25-000009.md) | [0.9](/filings/0000820318-25-000014.md) | [1.0](/filings/0000820318-25-000019.md) | [0.9](/filings/0000820318-26-000006.md) | [0.9](/filings/0000820318-26-000013.md) | [0.9](/filings/0000820318-26-000020.md) | [0.9](/filings/0000820318-25-000019.md) | [0.9](/filings/0000820318-26-000006.md) | [1.6](/filings/0000820318-26-000013.md) | [1.2](/filings/0000820318-26-000020.md) |
| Current assets | $bn | [3.2](/filings/0000820318-23-000029.md) | [3.4](/filings/0000820318-24-000004.md) | [3.6](/filings/0000820318-24-000009.md) | [3.7](/filings/0000820318-25-000014.md) | [3.6](/filings/0000820318-24-000035.md) | [3.5](/filings/0000820318-25-000004.md) | [3.7](/filings/0000820318-25-000009.md) | [3.9](/filings/0000820318-26-000020.md) | [4.0](/filings/0000820318-25-000019.md) | [4.4](/filings/0000820318-26-000006.md) | [6.4](/filings/0000820318-26-000013.md) | [6.9](/filings/0000820318-26-000020.md) |
| Total assets | $bn | [13.5](/filings/0000820318-24-000035.md) | [14.7](/filings/0000820318-24-000004.md) | [14.5](/filings/0000820318-24-000009.md) | [14.5](/filings/0000820318-25-000014.md) | [14.7](/filings/0000820318-24-000035.md) | [14.2](/filings/0000820318-25-000004.md) | [14.4](/filings/0000820318-25-000009.md) | [14.9](/filings/0000820318-26-000020.md) | [14.7](/filings/0000820318-25-000019.md) | [15.1](/filings/0000820318-26-000006.md) | [17.3](/filings/0000820318-26-000013.md) | [18.3](/filings/0000820318-26-000020.md) |
| Current liabilities | $bn | [1.1](/filings/0000820318-23-000029.md) | [1.2](/filings/0000820318-24-000004.md) | [1.3](/filings/0000820318-24-000009.md) | [1.3](/filings/0000820318-25-000014.md) | [1.4](/filings/0000820318-24-000035.md) | [1.3](/filings/0000820318-25-000004.md) | [1.5](/filings/0000820318-25-000009.md) | [1.8](/filings/0000820318-26-000020.md) | [1.7](/filings/0000820318-25-000019.md) | [2.0](/filings/0000820318-26-000006.md) | [2.1](/filings/0000820318-26-000013.md) | [2.9](/filings/0000820318-26-000020.md) |
| Total liabilities | $bn | [6.4](/filings/0000820318-23-000029.md) | [6.5](/filings/0000820318-24-000004.md) | [6.5](/filings/0000820318-24-000009.md) | [6.5](/filings/0000820318-25-000014.md) | [6.4](/filings/0000820318-24-000035.md) | [6.2](/filings/0000820318-25-000004.md) | [6.3](/filings/0000820318-25-000009.md) | [6.4](/filings/0000820318-26-000020.md) | [6.0](/filings/0000820318-25-000019.md) | [6.2](/filings/0000820318-26-000006.md) | [6.3](/filings/0000820318-26-000013.md) | [7.1](/filings/0000820318-26-000020.md) |
| Long-term debt | $bn | [4.2](/filings/0000820318-23-000029.md) | [4.1](/filings/0000820318-24-000004.md) | [4.1](/filings/0000820318-24-000009.md) | [4.0](/filings/0000820318-25-000014.md) | [3.9](/filings/0000820318-24-000035.md) | [3.8](/filings/0000820318-25-000004.md) | [3.7](/filings/0000820318-25-000009.md) | [3.5](/filings/0000820318-26-000020.md) | [3.3](/filings/0000820318-25-000019.md) | [3.2](/filings/0000820318-26-000006.md) | [3.2](/filings/0000820318-26-000013.md) | [3.2](/filings/0000820318-26-000020.md) |
| Current portion of debt | $bn | [0.1](/filings/0000820318-23-000029.md) | [0.1](/filings/0000820318-24-000004.md) | [0.1](/filings/0000820318-24-000009.md) | [0.1](/filings/0000820318-25-000014.md) | [0.1](/filings/0000820318-24-000035.md) | [0.0](/filings/0000820318-25-000004.md) | [0.0](/filings/0000820318-25-000009.md) | [0.2](/filings/0000820318-26-000020.md) | [0.0](/filings/0000820318-25-000019.md) | [0.1](/filings/0000820318-26-000006.md) | [0.0](/filings/0000820318-26-000013.md) | [0.0](/filings/0000820318-26-000020.md) |
| Shareholders' equity | $bn | [4.8](/filings/0000820318-23-000029.md) | [5.5](/filings/0000820318-24-000004.md) | [5.3](/filings/0000820318-24-000009.md) | [5.2](/filings/0000820318-25-000014.md) | [5.5](/filings/0000820318-24-000035.md) | [5.2](/filings/0000820318-25-000004.md) | [5.4](/filings/0000820318-25-000009.md) | [5.6](/filings/0000820318-26-000020.md) | [5.8](/filings/0000820318-25-000019.md) | [8.5](/filings/0000820318-26-000006.md) | [10.7](/filings/0000820318-26-000013.md) | [10.9](/filings/0000820318-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [199](/filings/0000820318-24-000035.md) | [67.2 d](/filings/0000820318-25-000004.md) | [117 d](/filings/0000820318-25-000009.md) | [162 d](/filings/0000820318-26-000020.md) | [153](/filings/0000820318-25-000019.md) | [187 d](/filings/0000820318-26-000006.md) | [163 d](/filings/0000820318-26-000013.md) | [130 d](/filings/0000820318-26-000020.md) | [46.0](/filings/0000820318-25-000019.md) | [57.9 d](/filings/0000820318-26-000006.md) | [(93.8) d](/filings/0000820318-26-000013.md) | [69.5 d](/filings/0000820318-26-000020.md) |
| Capital expenditure | $m | [62.2](/filings/0000820318-24-000035.md) | [91.5 d](/filings/0000820318-25-000004.md) | [93.2 d](/filings/0000820318-25-000009.md) | [99.9 d](/filings/0000820318-26-000020.md) | [92.0](/filings/0000820318-25-000019.md) | [106 d](/filings/0000820318-26-000006.md) | [112 d](/filings/0000820318-26-000013.md) | [131 d](/filings/0000820318-26-000020.md) | [104](/filings/0000820318-25-000019.md) | [154 d](/filings/0000820318-26-000006.md) | [290 d](/filings/0000820318-26-000013.md) | [556 d](/filings/0000820318-26-000020.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [133](/filings/0000820318-23-000029.md) | [139](/filings/0000820318-24-000004.md) | [139](/filings/0000820318-24-000009.md) | [150](/filings/0000820318-24-000035.md) | [152](/filings/0000820318-25-000004.md) | [152](/filings/0000820318-25-000009.md) | [154](/filings/0000820318-25-000019.md) | [160](/filings/0000820318-26-000006.md) | [155](/filings/0000820318-26-000013.md) | [191](/filings/0000820318-25-000019.md) | [193](/filings/0000820318-26-000006.md) | [196](/filings/0000820318-26-000013.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 195,832,246 at 2026-08-10, from the cover of the [10-K filed 2026-08-14](/filings/0000820318-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.